Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.565 USD | 0.00% | -21.53% | -96.26% |
05-14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-10 | Liquidation Plan and Disclosure Statement Filed by Acorda Therapeutics, Inc. | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
114B | ||||||
104B | ||||||
22.57B | - | |||||
22.5B | - | |||||
17.95B |